StockTipsArenaBeta

BUY MOLBIO DIAGNOSTICS LTD — Motilal Oswal

BUYMOLBIO DIAGNOSTICS LTD
MOLBIO DIAGNOSTICS share price target & all analyst calls

byMotilal OswalHorizon: NA (inferred 1 year)5 Oct 2026via Moneycontrol Broker Research

Entry₹1,503.4Inferred
Target₹1,800
Total upside +19.73%
Stop lossNot given
CMP₹1,501.1Just now
Active-0.15%+19.91%upside left 12 mo left
Follow Motilal Oswal for new calls(62% target hit, 1075 closed calls)Get alertsWatch MOLBIO for new buy/sell callsGet alertsSee 1 other Long-term call on MOLBIOSee 46 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 6 Oct, 4:18 pm IST
11 supporting2 neutral2 opposing
Supports the BUY call (11)

Motilal Oswal initiates coverage on Molbio Diagnostics stock with Buy, sees 21% upside. Here's why

NewsEt-Markets·6 Oct · today

(opens in new tab)

Molbio Diagnostics Shares In Focus As Motilal Oswal Initiates Coverage; Check Target Price

NewsNdtv-Profit·5 Oct · yesterday

(opens in new tab)

Molbio Diagnostics shares jump 5% as HDFC MF buys 1.99% stake via bulk deal | Newly listed stock up 71% from IPO price

NewsLivemint·1 Oct · 5d ago

(opens in new tab)

Molbio Diagnostics shares rally 9% as Jefferies initiates 'high conviction top pick' call for recently listed stock. Why is it bullish?

NewsEt-Markets·30 Sept · 6d ago

(opens in new tab)

Molbio Diagnostics Stock Soars 9% As It Becomes Jefferies Top Med Tech Pick At Initiation

NewsNdtv-Profit·30 Sept · 6d ago

(opens in new tab)
Neutral / worth noting (2)

Nothing found in this tip’s window yet.

Weighs against the BUY call (2)

Motilal Oswal Alternates sells over 2% stake in Molbio Diagnostics for ₹306 cr

NewsHbl·1 Oct · 5d ago

(opens in new tab)

Recently listed Molbio Diagnostics share price falls 9%: Healthcare stock loses 18.5% in 2 days after blockbuster rally

NewsLivemint·16 Sept · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on MOLBIO DIAGNOSTICS

All analyst calls on MOLBIO DIAGNOSTICS

More from Motilal Oswal

Every call and its outcome